This bundle of vibrant social media images contains interesting and educational information about cannabis, cannabinoids, the types of cannabis, and more!
Inside The Bundle
The Cannabis 101 Bundle includes 20 beautiful pieces of visual content:
(Image content provided by Maira Kuzminski-Vallejo @ThriveWithMaira).
- What is Cannabaceae?
Cannabaceae is a small family of flowering plants. As now circumscribed, the family includes about 170 species grouped in about 11 genera, including Cannabis (hemp, marijuana), Humulus (hops) and Celtis (hackberries). Celtis is by far the largest genus, containing about 100 species.
- Other Commonly Used Names for Cannabis
- Cannabis vs. Hemp
- Cannabis contains high levels of chemical compounds called cannabinoids that are used for medical benefits and recreational purposes.
- Hemp is industrially grown, primarily for the seeds, oils, stalks, and it contains fewer cannabinoids than the cannabis plant.
- Cannabis History of Human Use
- 4000 BC: Pan-p’o Village – Cannabis was was farmed as a major food crop.
- 2737 BC: Pen Ts’ao Ching – Earliest record of cannabis as a medicinal drug. At this time, Emperor Shen-Nung recognized its treatment properties for over 100 ailments such as gout, rheumatism, and malaria.
- 2000-1400 BC: Scythians – Nomadic Indo-European peoples used cannabis in steam baths and also burned cannabis seeds in burial rituals.
- 2000-1000 BC: Atharva Vedas – Cannabis was described as a “source of happiness”, “joy-giver and “bringer of freedom” in these Hindu religious texts. At this time cannabis was smoked at daily devotional services and religious rituals.
- 2000-1000 BC: Ayurvedic Medicine – Open religious use of cannabis allowed for exploration of medical benefits. Used to treat a variety of ailments such as epilepsy, anxiety, and bronchitis.
- 1550 BC: Ebers Papyrus – Open religious use of cannabis allowed for exploration of medical benefits. lt was used to treat a variety of ailments such as epilepsy, rabies, and anxiety.
- 1213 BC: Rawnesses II – Cannabis pollen has been recovered from the mummy of Ramesses II, the Egyptian pharaoh who was mummified after his death in 1213 BC.
- 900 BC Assyrians – Used psychotropic effects of cannabis for recreational and medical purposes.
- 450-200 BC: Greco-Roman Use – Physician Dioscorides prescribed cannabis for toothaches and earaches. Greek doctor Claudius Galen noted it was widely consumed throughout the empire. Women of the Roman elite also used it to alleviate childbirth pains.
- 207 AD: Hua T’o – First recorded physician to describe cannabis as an analgesic. He used a mixture of cannabis and wine to anaesthetize patients before surgery.
- 1000 AD: Treats Epilepsy – Arabic scholars al-Mayusi and al-Badri regard cannabis as an effective treatment for epilepsy.
- 1025 AD: Avicenna – The medieval Persian medical writer publishes “Avicenna’s Canon of Medicine” stating that cannabis is an effective treatment for gout, edema, infectious wounds, and severe headaches. His work was widely studied from the 13th to 19th centuries, having a lasting impact on Western medicine.
- 1300 AD: Arab Traders – Arab traders bring cannabis from India to Eastern Africa, where it spreads inland. It is used to treat malaria, asthma, fever, and dysentery.
- 1500 AD: Spanish Conquest – The Spanish brought cannabis to the Americas, where it was used for more practical purposes like rope or clothes.
- 1798: Napoleon – Napoleon brought cannabis back to France from Egypt and researched for its pain-relieving and sedative qualities. Also used to treat things like jaundice.
- 1839: William O’Shaughnessy – Introduced the therapeutic uses of cannabis to Western medicine. He concluded it had no negative effects and the plant’s pharmaceutical use grew rapidly.
- 1900: Medical Cannabis – Used to treat nausea, rheumatism, and childbirth pain. Available over-the-counter in medications such as “Piso’s cure” and “One day cough cure”.
- 1914: Harrison Act – Drug use was declared a crime in the U.S. under the Harrison Narcotics Tax Act.
- 1937: Marihuana Tax Act – The Marihuana Tax Act banned the use and sales of cannabis in the U.S.
- 1964: Discovery of THC – THC was discovered by Israeli chemist Dr Raphael Mechoulam.
- 1970: Classified as Schedule 1 Drug – Listed as having “no accepted medical use”. This limited further research.
- 1988: CBD Receptors Discovered – The CBD1 and CBD2 cannabinoid receptors were discovered. Today, we know they are some of the most abundant neuroreceptors in the brain.
- 2000-2018: Medical Cannabis Legalization – Governments, such as those of Canada and various states, begin to legalize cannabis for medical purposes from licensed producers. Recreational legalization quickly starts to follow.
- Cannabis Sativa
- Experience: creative, euphoric, uplifting.
- Potential therapeutic values: mood-lifting for daytime use.
- Physical appearance: grows between 5-18 ft tall, thinly leaved, few branches.
- Cannabis Indica
- Experience: sedative, relaxing.
- Potential therapeutic values: sedation, pain relief, reduces nausea, improves appetite, nighttime use.
- Physical appearance: grows 2 to 4 ft tall, broad-leaved, compact leaves and branches, bushy appearance, wider flowers.
- Cannabis Ruderalis
- Experience: relaxed but focused.
- Potential therapeutic values: low THC could be used to address depression.
- Physical appearance: grows under 2ft tall, unbranched, auto-flowering.
- Cannabinoids are the dominant compounds in cannabis. They influence the endocannabinoid system, which all mammals have. They activate or inhibit cannabinoid receptors (CB1 or CB2) which lead to the many associated pharmaceutical effects on humans.
- Tetrahydrocannabinol (THC)
The main cannabinoid found in most sativa and indica strain of cannabis. It interacts mainly with CB1 receptors. It is the most widely studied cannabinoid and it has been shown to have many medical applications. Responsible for the “high” feeling, psychotropic.
Observed therapeutic benefits: anti-inflammatory, muscle relaxant, neuro-antioxidative, antispasmodic activities, analgesic, pain relief.
- Cannabidiol (CBD)
CBD is the second most common cannabinoid in cannabis.
No known interaction with either CB1 or CB2.
Mitigates the psychoactive experience of THC.
Observed therapeutic benefits: neuroprotective, mood modulation, antipsychotic, anti-inflammatory, anti-seizure, anti-anxiety.
- Cannabichromene (CBC)
Third most common cannabinoid, observed to extend the lifespan of an endocannabinoid we naturally produce in the body called anandamide, also known as the “bliss” molecule.
Observed therapeutic benefits: anti-inflammatory, pain relief, antifungal, sedative, antibacterial.
- Cannabinol (CBN)
Associated with aged cannabis, it is a degraded product of THC. Has low affinity to the CB1 receptor than THC, but a higher affinity to CB2.
Observed therapeutic benefits: anti-nausea and vomiting associated with chemotherapy, appetite stimulation, anti-spasticity associated with Multiple Sclerosis.
- Phytochemicals are responsible for the aroma and taste of plants, including cannabis. More than 100 have been identified. The same terpenes in cannabis can also be found in other fruits, vegetables, and herbs. Each cannabis strain contains a different terpene profile, which is often incorporated into its strain names. They have been observed to have medicinal benefits in isolation or together with other cannabinoids in a phenomenon called the “Entourage Effect”.
- Entourage Effect
The combined effect of different compounds found in cannabis that work together as a whole to produce a greater effect than if working separately to produce separate effects.
A chemical reaction that changes molecular structures. In fresh cannabis, most of the cannabinoids have a carboxyl group, which are released when heat is applied. Each cannabinoid has a different heat sensitivity to release the carboxyl group and become active. For example, fresh cannabis contains THCA when heated, vaporized, smoked, or baked in turn into THC the activated cannabinoid that produces psychotropic effects.
- Cannabis Formats for Medical
– Raw flower
Cannabis Formats for Recreational
– Raw flower
– Vape oils
- Cannabis Consumption Methods
INHALATION: Inhalation is the most common way people have traditionally consumed cannabis. The onset of effects is rapid with most people feeling a “high” within minutes of inhalation. Common examples of delivery methods using inhalation are: hand pipe, bong, vaporizer, joint and hookah.
ORAL-MUCOSAL: The product (most commonly a tincture) is applied under the tongue or sprayed into the mouth and absorbed through the oral-mucosal lining.
INGESTION: Ingesting cannabis is most commonly in the form of a food or beverage item that was created using a fat or oil infused with cannabis that was then heated to ensure the cannabinoids are active when consumed. Edibles include any food or drink that contains cannabis.
TOPICAL: Topical cannabis products are applied and absorbed through the skin using a thick oil extract that contains active cannabinoids. The effects of the cannabinoids are generally localized and use of the product is generally not to confer intoxicating effects, but to provide localized relief from pain on inflammatory conditions (some exceptions apply).
- Cannabis Use Disorder
While the research is still evolving concerning the potential harms associated with cannabis consumption, the likelihood of developing a problematic relationship with cannabis (Cannabis Use Disorder or CUD) depends upon four factors:
- LENGTH AND INTENSITY OF CONSUMPTION – Longer, more intense consumption increases risk.
- POTENCY OFTHE PRODUCT – Consuming high levels of THC is more addictive.
- INDIVIDUAL FACTORS – Genetic factors or individual vulnerabilities, such as personality or experiences of trauma, can impact whether a person experiences harm.
- AGE OF INITIATION – People who begin to consume cannabis at a young age (under 16 years old) at a high frequency are at greater risk.
- Cannabis Short Term Risks
Associated with the method of consumption, mainly smoking of THC dominant strains, some include: increased risk for the development of bronchitis, chronic cough and increased phlegm production. Increased risk of death and injury when operating vehicles or heavy machinery.
- Cannabis Long Term Risks
Exaggerated and prolonged use can increase risk of developing schizophrenia, social anxiety disorder, may increase symptoms of bipolar disorder, increase depression and demotivation. May cause dependency.